What's in Ionis Pharmaceuticals, Inc.'s pipeline?

Ionis Pharmaceuticals, Inc. has 45 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 20 in Phase 2, 23 in Phase 1.

Which companies overlap with Ionis Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Avidity Biosciences, Inc., European Organisation for Research and Treatment of Cancer - EORTC, Hoffmann-La Roche, Isarna Therapeutics GmbH, Leadiant Biosciences, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ionis-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Ionis Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ionis Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 20 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 20 Phase 2 23 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ION363	ION363	phase 3	Antisense oligonucleotide	APOC3 mRNA	Cardiovascular
ION582	ION582	phase 3	Antisense oligonucleotide; ApoB inhibitor	Apolipoprotein B (ApoB) mRNA	Cardiovascular

Therapeutic area mix

Cardiovascular · 3
Endocrinology · 1
Metabolic/Endocrinology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Avidity Biosciences, Inc. · 2 shared drug classes
European Organisation for Research and Treatment of Cancer - EORTC · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Isarna Therapeutics GmbH · 1 shared drug class
Leadiant Biosciences, Inc. · 1 shared drug class
NYU Langone Health · 1 shared drug class
Pfizer · 1 shared drug class
Sarepta Therapeutics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ionis Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Ionis Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ionis-pharmaceuticals-inc. Accessed 2026-05-17.